Université de Paris Cité, F-75015, Paris, France.
Assistance Publique-Hôpitaux de Paris (AP-HP), Service de Chirurgie Digestive, Oncologique Et Bariatrique, Hôpital Européen Georges Pompidou, Paris, France.
Obes Surg. 2022 Sep;32(9):2839-2845. doi: 10.1007/s11695-022-06203-9. Epub 2022 Jul 8.
It has been suggested that shortening the length of the biliopancreatic limb (BPL) to 150 cm in one anastomosis gastric bypass (OAGB) would reduce nutritional complication rates without impairing weight loss outcomes. The aim of this study is to compare patients who underwent OAGB with a 200-cm BPL (OAGB-200) to patients with OAGB with a 150-cm BPL (OAGB-150) in terms of weight loss and late morbidity.
This is a monocentric retrospective matched cohort study including patients with a body mass index between 35 and 50 kg/m who underwent an OAGB-150 or an OAGB-200. Patients were matched 1:1 based on age, sex, and body mass index, prior to bariatric surgery.
In total, 784 patients who underwent OAGB were included (OAGB-150 n = 392 and OAGB-200 (n = 392). There was no significant difference in terms of early morbidity. Regarding late morbidity in patients with an OAGB-150, significantly lower rates for marginal ulcer (OR = 0.4, CI 95% [0.2; 0.8], p = 0.006), incisional hernia (OR = 0.5, CI 95% [0.3; 1], p = 0.041), and bowel obstruction (OR = 0.3, CI 95% [0.1; 0.9], p = 0.039) were reported. Likewise, regarding late nutritional deficiencies, post-OAGB-150, a significantly lower number of patients with hypoalbuminemia (OR = 0.3, CI 95% [0.2; 0.7], p = 0.006), low vitamin B9 (OR = 0.5, CI 95% [0.2; 1], p = 0.044), and low ferritin (OR = 0.5, CI 95% [0.3; 0.8], p = 0.005) were observed. There was no significant difference in the percentage of excess BMI loss at 1, 2, 3, 4, and 5 years.
Compared to OAGB-200 in patients with BMI ≤ 50 kg/m, OAGB-150 results in fewer nutritional deficiency rates long term, without impairing weight loss.
有研究表明,在一吻合胃旁路术(OAGB)中将胆胰支缩短至 150cm 可以降低营养并发症的发生率,而不会影响减重效果。本研究旨在比较胆胰支长度为 200cm(OAGB-200)和 150cm(OAGB-150)的 OAGB 患者在减重和晚期发病率方面的差异。
这是一项单中心回顾性匹配队列研究,纳入了 BMI 在 35-50kg/m 之间接受 OAGB-150 或 OAGB-200 的患者。在接受减重手术之前,根据年龄、性别和 BMI 对患者进行 1:1 匹配。
共纳入 784 例接受 OAGB 的患者(OAGB-150 组 n=392,OAGB-200 组 n=392)。两组早期发病率无显著差异。OAGB-150 组患者的晚期发病率中,边缘性溃疡(OR=0.4,95%CI [0.2; 0.8],p=0.006)、切口疝(OR=0.5,95%CI [0.3; 1],p=0.041)和肠梗阻(OR=0.3,95%CI [0.1; 0.9],p=0.039)的发生率显著降低。同样,在晚期营养缺乏方面,OAGB-150 组患者低白蛋白血症(OR=0.3,95%CI [0.2; 0.7],p=0.006)、维生素 B9 缺乏(OR=0.5,95%CI [0.2; 1],p=0.044)和铁蛋白缺乏(OR=0.5,95%CI [0.3; 0.8],p=0.005)的发生率显著降低。两组患者在术后 1、2、3、4 和 5 年时的 BMI 过量损失百分比无显著差异。
与 BMI≤50kg/m 的患者接受 OAGB-200 相比,OAGB-150 可长期降低营养缺乏的发生率,而不会影响减重效果。